Novo Nordisk Foundation's BioInnovation Institute has funded seven new projects with debt financing and grants to progress research in areas like male infertility and stem cell therapies.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

JD.com's medical products spinoff has gone public in Hong Kong's largest initial public offering this year, valuing it at close to $29bn.

Rock Springs has led a round that will drive R&D and recruitment at AI drug design company Genesis Therapeutics, which emerged out of Stanford.

Johns Hopkins and Pitt-linked digital pathology platform Proscia has increased its funding total to $35m with a series B round involving Hitachi Ventures.

Digital pathology technology developer Proscia has boosted its total funding to $35m with a series B round featuring Hitachi Ventures.

Cancer and graft-versus-host disease therapy developer MaaT has raised a second tranche to hike the Biocodex-backed round to $30.4m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

GV was among the participants in the healthcare management platform developer's third round this year, valuing it at $1.5bn.

The diabetes treatment developer, which counts Tasly and Legend Star among its investors, has received what it referred to as pre-IPO funding.